NR4A1 and breast cancer: The hazard ratio (HR) was statistically significant in HR+HER2+ (HR = 1.18, p < 0.001) and HR+HER2-, demonstrating that the ECMI is a reliable risk factor in BC when both hormone receptor and HER2 are positive.